Classic Psychedelic Drugs: Update on Biological Mechanisms
- PMID: 35079988
- PMCID: PMC9110100
- DOI: 10.1055/a-1721-2914
Classic Psychedelic Drugs: Update on Biological Mechanisms
Abstract
Renewed interest in the effects of psychedelics in the treatment of psychiatric disorders warrants a better understanding of the neurobiological mechanisms underlying the effects of these substances. During the past two decades, state-of-the-art studies of animals and humans have yielded new important insights into the molecular, cellular, and systems-level actions of psychedelic drugs. These efforts have revealed that psychedelics affect primarily serotonergic receptor subtypes located in cortico-thalamic and cortico-cortical feedback circuits of information processing. Psychedelic drugs modulate excitatory-inhibitory balance in these circuits and can participate in neuroplasticity within brain structures critical for the integration of information relevant to sensation, cognition, emotions, and the narrative of self. Neuroimaging studies showed that characteristic dimensions of the psychedelic experience obtained through subjective questionnaires as well as alterations in self-referential processing and emotion regulation obtained through neuropsychological tasks are associated with distinct changes in brain activity and connectivity patterns at multiple-system levels. These recent results suggest that changes in self-experience, emotional processing, and social cognition may contribute to the potential therapeutic effects of psychedelics.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9110100/bin/10-1055-a-1721-2914-i2021-05-1038-0001.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9110100/bin/10-1055-a-1721-2914-i2021-05-1038-0002.gif)
Similar articles
-
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders.Nat Rev Neurosci. 2020 Nov;21(11):611-624. doi: 10.1038/s41583-020-0367-2. Epub 2020 Sep 14. Nat Rev Neurosci. 2020. PMID: 32929261 Review.
-
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.Nat Rev Neurosci. 2010 Sep;11(9):642-51. doi: 10.1038/nrn2884. Epub 2010 Aug 18. Nat Rev Neurosci. 2010. PMID: 20717121 Review.
-
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.Curr Neuropharmacol. 2017;15(7):1032-1042. doi: 10.2174/1573413713666170619092629. Curr Neuropharmacol. 2017. PMID: 28625125 Free PMC article. Review.
-
Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.J Neurosci. 2023 Nov 8;43(45):7472-7482. doi: 10.1523/JNEUROSCI.1384-23.2023. J Neurosci. 2023. PMID: 37940583 Free PMC article. Review.
-
More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics.Neuropharmacology. 2023 Feb 1;223:109300. doi: 10.1016/j.neuropharm.2022.109300. Epub 2022 Nov 9. Neuropharmacology. 2023. PMID: 36334767 Review.
Cited by
-
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147. Curr Neuropharmacol. 2024. PMID: 38284341 Free PMC article. Review.
-
Molecular and Medical Aspects of Psychedelics.Int J Mol Sci. 2023 Dec 23;25(1):241. doi: 10.3390/ijms25010241. Int J Mol Sci. 2023. PMID: 38203411 Free PMC article. Review.
-
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study.Int J Mol Sci. 2023 Dec 20;25(1):100. doi: 10.3390/ijms25010100. Int J Mol Sci. 2023. PMID: 38203271 Free PMC article.
-
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential.Mol Psychiatry. 2024 Mar;29(3):671-685. doi: 10.1038/s41380-023-02360-0. Epub 2024 Jan 4. Mol Psychiatry. 2024. PMID: 38177350 Review.
-
Drug-drug interactions involving classic psychedelics: A systematic review.J Psychopharmacol. 2024 Jan;38(1):3-18. doi: 10.1177/02698811231211219. Epub 2023 Nov 20. J Psychopharmacol. 2024. PMID: 37982394 Free PMC article. Review.
References
-
- Hofmann A, Heim R, Brack A et al.Psilocybin und psilocin, zwei psychotrope wirkstoffe aus Mexikanischen rauschpilzen. Helv chim Acta. 1959;42:1557–1572.
-
- Schultes R E, Hofmann A.The botany and chemistry of hallucinogens2 edn.Springfield: Charles C. Thomas; 1980
-
- Nichols D E. Hallucinogens. Pharmacol Ther. 2004;101:131–181. - PubMed
-
- Dittrich A, von Arx S, Staub S. International study on altered states of consciousness (ISASC). Summary of the results. Germ J Psych. 1985;9:319–339.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous